Background Experimental studies and small clinical trials have suggested that treatment with
intranasal oxytocin may reduce social impairment in persons with autism spectrum disorder…

A role for immunological involvement in autism spectrum disorder (ASD) has long been
hypothesized. This review includes four sections describing (1) evidence for a relationship …

Introduction: Comorbid psychiatric disorders are common in Down syndrome (DS). Evidence
for pharmacotherapy of psychiatric co-morbidity in DS is limited. Areas covered: This article …

An immune-mediated subtype of autism spectrum disorder (ASD) has long been hypothesized.
This article reviews evidence from family history studies of autoimmunity, immunogenetics…

Adults with autism spectrum disorder (ASD) are at risk for excess bodyweight and hypertension,
yet the prevalence of and clinical predictors for these health conditions remain unknown. …

This study was a 10-week double-blind, placebo-controlled pilot trial of mirtazapine for anxiety
in youth with autism spectrum disorder (ASD). Participants were ages 5 to 17 years with …

Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social
salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) …

Sex-based differences in the prevalence of autism spectrum disorder (ASD) are well-documented,
with a male-to-female ratio of approximately 4:1. The clinical presentation of the core …

Background: Depression is a common psychiatric comorbidity in individuals with Down
syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 10%. The …

Objectives Angelman syndrome (AS) is a neurogenetic disorder associated with impaired
expression of the ubiquitin-protein ligase E3A gene on chromosome 15. AS results in …